ArticleDiagnostics (Basel, Switzerland)2021
Genomic Characterization of VIM and MCR Co-Producers: The First Two Clinical Cases, in Italy.
Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 24 citations in OpenAlex.
- Plasmid-borneOne health (Amsterdam, Netherlands) · 2026Article
- Colistin resistance in the era of antimicrobial resistance: challenges and strategic countermeasures.Folia microbiologica · 2025Review
- The burden of infections caused by Metallo-Beta-Lactamase-Producing Enterobacterales in Italy: epidemiology, outcomes, and management.Le infezioni in medicina · 2025Review
- Mobile colistin resistanceJAC-antimicrobial resistance · 2023Article
- First Detection ofAntibiotics (Basel, Switzerland) · 2023Article
- Plasmid-mediated colistin resistance among human clinicalFrontiers in microbiology · 2023Article
- Novel Plasmid Carrying Mobile Colistin Resistance GeneMicrobiology spectrum · 2022Article
- Wastewater-based surveillance in Italy leading to the first detection of mcr-10-positive Klebsiella quasipneumoniae.Antimicrobial resistance and infection control · 2022Article
- Chromosomal coharboring of blaBMC infectious diseases · 2022Article
- Screening ofPolish journal of microbiology · 2022Article
- Resistance Patterns,Animals : an open access journal from MDPI · 2022Article
- Implication of different replicons in the spread of the VIM-1-encoding integron, In110, in Enterobacterales from Czech hospitals.Frontiers in microbiology · 2022Article
- Reduction trend of mcr-1 circulation in Emilia-Romagna Region, Italy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021Article
- Emergence of IncHI2 Plasmids WithFrontiers in microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 2 countries.
Funding
Abstract
backgroundthe co-production of carbapenemases and
methodsspecies identification and antibiotic susceptibility profiling were performed using MALDI-TOF and broth microdilution methods, respectively. Transferability of the
resultsthe first isolate showed clinical resistance against ertapenem yet was colistin susceptible (EUCAST 2020 breakpoints). The
conclusionsto our knowledge, this is the first report of co-production of VIM and MCR in ECC isolates in Italy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.